UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in PGEN — Precigen, Inc.
CIK 861177
NEW YORK, NY
Position in PGEN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,372,141
+$394,662 QoQ
Shares Held
354,559
+51.6% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 27%
Shared 0%
None 73%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. PGEN ranks #117 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in PGEN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,372,141 | 354,559 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $977,479 | 233,847 | Shares | Sole | 2026-02-13 | |
| 2023-06-30 | $123,132 | 107,073 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $113,496 | 107,073 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $201,980 | 132,883 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $281,711 | 132,883 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $229,188 | 171,038 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $206,462 | 97,850 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $363,022 | 97,850 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $488,268 | 97,850 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $637,980 | 97,850 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $618,933 | 89,831 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $783,675 | 76,831 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $308,108 | 88,031 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $439,272 | 88,031 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $324,101 | 95,324 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||